RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mingli Liu to Cyclin-Dependent Kinase Inhibitor p27

Back to Details
This is a "connection" page, showing publications Mingli Liu has written about Cyclin-Dependent Kinase Inhibitor p27.
Mingli Liu
Connection Strength
0.936
Cyclin-Dependent Kinase Inhibitor p27
  1. Ramar V, Sidhu RS, Pako O, Cisse CR, Guo AA, Li J, Stapleton K, Guo S, Wang G, Liu M. TRIM21 functions as an oncogene in glioblastoma by transactivating FOSL1 and promoting the ubiquitination of p27. Cell Commun Signal. 2025 Jul 01; 23(1):313.
    View in: PubMed
    Score: 0.936
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support